Article
Genetic variation supports a causal role for valproate in prevention of ischemic stroke.
International journal of stroke : official journal of the International Stroke Society - 1 Jan 2024
Mayerhofer Ernst, Parodi Livia, Narasimhalu Kaavya, Wolking Stefan, Harloff Andreas, Georgakis Marios K, Rosand Jonathan, Anderson Christopher D
Abstract excerpt
BACKGROUND: Valproate is a candidate for ischemic stroke prevention due to its anti-atherosclerotic effects in vivo. Although valproate use is associated with decreased ischemic stroke risk in observational studies, confounding by indication precludes causal conclusions. AIMS: We applied Mendelian randomization to determine whether genetic variants that influence seizure response among valproate users associate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
